| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB3028-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2824-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76419-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77256-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34870-10ug | |||
| Carrier-Free | NBP2-34870-1mg | |||
| Carrier-Free | NBP2-34870-500ug | |||
![Western Blot: IL-31 Antibody [NBP1-76419] - Human skeletal muscle tissue lysate with IL-31 antibody at (A) 2.5, (B) 5 and (C) 10 ug/ml.](http://images.novusbio.com/fullsize/IL-31-Antibody-Western-Blot-NBP1-76419-img0001.jpg "Western Blot: IL-31 Antibody [NBP1-76419] - Human skeletal muscle tissue lysate with IL-31 antibody at (A) 2.5, (B) 5 and (C) 10 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: IL-31 Antibody - BSA Free [NBP1-76419] - Immunofluorescence of IL-31 in Human Skeletal Muscle cells with IL-31 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76419_rabbit-polyclonal-il-31-antibody-2711202419553051.jpg)
![Western Blot: IL-31 Antibody [NBP1-77256] - RAW264.7 cell lysate with IL-31 antibody at (A) 2.5, (B) 5 and (C) 10 ug/ml.](http://images.novusbio.com/fullsize/IL-31-Antibody-Western-Blot-NBP1-77256-img0002.jpg "Western Blot: IL-31 Antibody [NBP1-77256] - RAW264.7 cell lysate with IL-31 antibody at (A) 2.5, (B) 5 and (C) 10 ug/ml.")
![Immunohistochemistry: IL-31 Antibody - BSA Free [NBP1-77256] - Immunohistochemistry of IL-31 in rat skeletal muscle tissue with IL-31 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77256_rabbit-polyclonal-il-31-antibody-2711202420141975.jpg)
![Western Blot: IL31 Overexpression Lysate (Adult Normal) [NBL1-11951] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for IL31.](http://images.novusbio.com/fullsize/IL31-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-11951-img0002.jpg "Western Blot: IL31 Overexpression Lysate (Adult Normal) [NBL1-11951] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for IL31.")
![SDS-Page: Recombinant Human IL-31 Protein [NBP2-34870] - SDS-PAGE with Recombinant human IL-31 protein.](http://images.novusbio.com/fullsize/Recombinant-Human-IL-31-Protein-SDS-Page-NBP2-34870-img0001.jpg "SDS-Page: Recombinant Human IL-31 Protein [NBP2-34870] - SDS-PAGE with Recombinant human IL-31 protein.")
![Western Blot: IL-31 Antibody (A3) [NBP3-41902] - Sample: Recombinant IL-31, Rat.](http://images.novusbio.com/fullsize/nbp3-41902_mouse-il-31-mab-a3-61220242116212.jpg "Western Blot: IL-31 Antibody (A3) [NBP3-41902] - Sample: Recombinant IL-31, Rat.")
![SDS-Page: Recombinant Canine IL-31 Protein [NBP2-77493] - 3ug under reducing condition and visualized by coomassie blue stain](http://images.novusbio.com/fullsize/Recombinant-Canine-IL-31-Protein-SDS-Page-NBP2-77493-img0001.jpg "SDS-Page: Recombinant Canine IL-31 Protein [NBP2-77493] - 3ug under reducing condition and visualized by coomassie blue stain")
![Neutralization: IL-31 Antibody (MT313) [NBP3-18293] - Neutralization of human IL-31 induced IL-6 production (see graph). To determine the neutralizing capacity and ND50, mixtures of human recombinant IL-31 (50 ng/ml) and various concentrations of NBP3-18293 were added to human aortic endothelial cells that had been pre-stimulated with recombinant human IFN-gamma (10 ng/ml). Following overnight incubation, cell supernatants were quantified in IL-6 ELISA.](http://images.novusbio.com/fullsize/IL-31-Antibody-MT313-Neutralization-NBP3-18293-img0001.jpg "Neutralization: IL-31 Antibody (MT313) [NBP3-18293] - Neutralization of human IL-31 induced IL-6 production (see graph). To determine the neutralizing capacity and ND50, mixtures of human recombinant IL-31 (50 ng/ml) and various concentrations of NBP3-18293 were added to human aortic endothelial cells that had been pre-stimulated with recombinant human IFN-gamma (10 ng/ml). Following overnight incubation, cell supernatants were quantified in IL-6 ELISA.")